Roche's Full-Year Results 2022
Pharmaceuticals Division
Diagnostics Division
Financial Results
Questions and answers
Severin Schwan, CEO Roche Group
Thomas Schinecker, Designated CEO Roche Group as of 15 March 2023 and ad interim CEO Roche Pharmaceuticals
Matt Sause, CEO Roche Diagnostics
Alan Hippe, Chief Financial and IT Officer
Bruno Eschli, Head of Investor Relations

Webinar Replay

Please register here to access the replay*

*Privacy notice

Past IR Events
View more Events

Roche has published its Full-Year Results for 2022 prior to the opening of the Swiss Stock Exchange on Thursday, 2nd February 2023.


Discover more